Atossa Genetics works as a healthcare company focused on the development of a laboratory services, medical devices and therapeutics for breast cancer in the U.S. ATOS markets nipple aspirate fluid (NAF) cytology and pharmacogenomics tests. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator devices that are used for collecting of NAF for cytological laboratory testing.  Founded in 2009, the company is based in Seattle, Washington.  For more information, visit the company’s website at www.atossagenetics.com